Menu
  • US concern over India IPR misplaced

    US concern over India's IPR misplaced

    Attachment File: Download (50.04 KB) pdf
  • Ranbaxy loses 180-day exclusivity for generic Nexium

    Ranbaxy loses 180-day exclusivity for generic Nexium

    Attachment File: Download (46.79 KB) pdf
  • India, US officials to meet after Budget to discuss investment

    India, US officials to meet after Budget to discuss investment

    Attachment File: Download (112.05 KB) pdf
  • Patent row no hurdle for gilead sovaldi launch

    Patent row no hurdle for gilead's sovaldi launch

    Attachment File: Download (33.36 KB) pdf
  • HC asks patent office to review Gilead case

    HC asks patent office to review Gilead's case

    Attachment File: Download (39.53 KB) pdf
  • US official claims commitments from India on IPR

    US official claims commitments from India on IPR

    Attachment File: Download (64.48 KB) pdf
  • Duality finger at US drug patent call

    Duality finger at US drug patent call

    Attachment File: Download (42.81 KB) pdf
  • Patent laws: Are we losing the battle

    Patent laws: Are we losing the battle?

    Attachment File: Download (85.15 KB) pdf
  • Patent dispute: Novartis objects to Wockhardt filing fresh documents

    Patent dispute: Novartis objects to Wockhardt filing fresh documents

    Attachment File: Download (62.52 KB) pdf
  • No question of appeasing US or anyone else on IPR: Nirmala

    No question of appeasing US or anyone else on IPR: Nirmala

    Attachment File: Download (34.14 KB) pdf

Pages